Haemonetics Corporation (FRA:HAZ)
Germany
· Delayed Price · Currency is EUR 69.00
-0.50 (-0.72%)
At close: Dec 4, 2025
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2014 - 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 27, 2025 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | 2014 - 2021 |
| United States Revenue | 988.45M | 1.01B |
Log In |
Log In |
Log In | Upgrade
|
| Japan Revenue | 63.94M | 62.41M |
Log In |
Log In |
Log In | Upgrade
|
| Europe Revenue | 170.29M | 175.66M |
Log In |
Log In |
Log In | Upgrade
|
| Asia Revenue | 90.97M | 92.31M |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographic Revenue | 14.21M | 19.54M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 1.33B | 1.36B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown
Fiscal year is April - March.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2014 - 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 27, 2025 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | 2014 - 2021 |
| Plasma Products and Services Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Blood Center Products and Services Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Hospital Products and Services Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 1.33B | 1.36B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 1.33B | 1.36B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 2
Fiscal year is April - March.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2014 - 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 27, 2025 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | 2014 - 2021 |
| Plasma Revenue | 516.22M | 535.43M |
Log In |
Log In |
Log In | Upgrade
|
| Blood Center Revenue | 234.64M | 261.12M |
Log In |
Log In |
Log In | Upgrade
|
| Hospital Revenue | 576.99M | 564.27M |
Log In |
Log In |
Log In | Upgrade
|
| Service Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Effect of Exchange Rates on Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 1.33B | 1.36B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is April - March.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2014 - 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 27, 2025 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | 2014 - 2021 |
| Plasma Segment Operating Income (Post-Q3 2025 Reporting) | - | 184.51M |
Log In |
Log In |
Log In | Upgrade
|
| Blood Center Segment Operating Income (Post-Q3 2025 Reporting) | - | 52.82M |
Log In |
Log In |
Log In | Upgrade
|
| Hospital Segment Operating Income (Post-Q3 2025 Reporting) | - | 88.98M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | 230.68M | -104.49M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 230.68M | 221.82M |
Log In |
Log In |
Log In | Upgrade
|
EBIT 2
Fiscal year is April - March.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2014 - 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 27, 2025 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | 2014 - 2021 |
| Plasma Segment Operating Income | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Blood Center Segment Operating Income | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Hospital Segment Operating Income | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 230.68M | 221.82M |
Log In |
Log In |
Log In | Upgrade
|